Evidence map›Paper›PMID 21543766›Full record

ArticleBiology of reproduction2011

Krüppel-like factor 9 loss-of-expression in human endometrial carcinoma links altered expression of growth-regulatory genes with aberrant proliferative response to estrogen.

Christian D Simmons, John Mark P Pabona, Melissa E Heard, Theodore M Friedman, Michael T Spataro, Amy L Godley, Frank A Simmen, Alexander F Burnett, Rosalia C M Simmen

Open access · bronzeAbstract read
In one paragraph

Article in Biology of reproduction, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.Reproductive sciences (Thousand Oaks, Calif.) · 2020
    Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. HypermethylatedOncoTargets and therapy · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Krüppel-like factors are effectors of nuclear receptor signaling.General and comparative endocrinology · 2014
    Review
  17. Article
  18. Article
  19. Krüppel-like factors in cancer.Nature reviews. Cancer · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christian D SimmonsDepartments of Physiology & Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202, USA.
John Mark P Pabona
Melissa E Heard
Theodore M Friedman
Michael T Spataro
Amy L Godley
Frank A Simmen
Alexander F Burnett
Rosalia C M Simmen
University of Arkansas for Medical Sciences · USArkansas Children's Nutrition Center · US

Funding

UTEROFERRIN GENE EXPRESSION DURING DEVELOPMENTR01HD021961 · NICHD · UNIVERSITY OF FLORIDA · PI SIMMEN, ROSALIA C · 1991 to 2008
$2.1M
UTEROFERRIN GENE EXPRESSION DURING DEVELOPMENTR29HD021961 · NICHD · UNIVERSITY OF FLORIDA · PI SIMMEN, ROSALIA C · 1986 to 1990
–
NICHD NIH HHS HD21961NICHD NIH HHS R01 HD021961
6 · The paper itself

Abstract

Endometrial cancer is the most commonly diagnosed female genital tract malignancy. Krüppel-like factor 9 (KLF9), a member of the evolutionarily conserved Sp family of transcription factors, is expressed in uterine stroma and glandular epithelium, where it affects cellular proliferation, differentiation, and apoptosis. Deregulated expression of a number of Sp proteins has been associated with multiple types of human tumors, but a role for KLF9 in endometrial cancer development and/or progression is unknown. Here, we evaluated KLF9 expression in endometrial tumors and adjacent uninvolved endometrium of women with endometrial carcinoma. KLF9 mRNA and protein levels were lower in endometrial tumors coincident with decreased expression of family member KLF4 and growth-regulators FBJ murine osteosarcoma viral oncogene homolog (FOS) and myelocytomatosis viral oncogene homolog (MYC) and with increased expression of telomerase reverse transcriptase (TERT) and the chromatin-modifying enzymes DNA methyltransferase 1 (DNMT1) and histone deacetylase 3 (HDAC3). Expression of estrogen receptor alpha (ESR1) and the tumor-suppressor phosphatase and tensin homolog deleted in chromosome 10 (PTEN) did not differ between tumor and normal tissue. The functional relevance of attenuated KLF9 expression in endometrial carcinogenesis was further evaluated in the human endometrial carcinoma cell line Ishikawa by siRNA targeting. KLF9 depletion resulted in loss of normal cellular response to the proliferative effects of estrogen concomitant with reductions in KLF4 and MYC and with enhancement of TERT and ESR1 gene expression. Silencing of KLF4 did not mimic the effects of silencing KLF9 in Ishikawa cells. We suggest that KLF9 loss-of-expression accompanying endometrial carcinogenesis may predispose endometrial epithelial cells to mechanisms of escape from estrogen-mediated growth regulation, leading to progression of established neoplasms.

Indexed as

AdultAgedCarcinomaCell ProliferationCells, CulturedEndometrial NeoplasmsEndometriumEstrogensFemaleGene Expression Regulation, NeoplasticGene SilencingHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsMiddle AgedEstrogensKLF4 protein, humanKLF9 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription Factors

Identifiers

PMID21543766
PMCPMC3142261
OpenAlexW2147043210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.